Retina Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania; Mid-Atlantic Retina, Plymouth Meeting, Pennsylvania; Eye Research Institute, Philadelphia, Pennsylvania; Center for Value-Based Medicine, Flourtown, Pennsylvania.
Research Unit, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania; Eye Research Institute, Philadelphia, Pennsylvania; Center for Value-Based Medicine, Flourtown, Pennsylvania.
Ophthalmology. 2015 Oct;122(10):2084-94. doi: 10.1016/j.ophtha.2015.06.025. Epub 2015 Aug 3.
To assess the character and cause of photopsias in vitreoretinal patients.
Cross-sectional study.
A total of 169 consecutive patients (217 eyes) with vitreoretinal disease presenting with a history of photopsias.
A total of 217 eyes with photopsias in 169 patients were evaluated. Photopsia assessment included (1) laterality (unilateral, bilateral but not simultaneous, bilateral, and simultaneous); (2) morphology (flash, zig-zag, strobe, scintillating scotoma, twinkling, other); (3) color (white, silver, yellow, combination, other); (4) location (temporal, central, other); (5) duration (quick, prolonged, constant, other); (6) frequency; (7) diurnal appearance (day, night, both); (8) stimuli (turning head or eyes, hypoglycemia, hyperglycemia, other); and (9) associated systemic or ocular signs and symptoms (headache, numbness, weakness, vertigo, syncope, diplopia, hypotension, floaters, other).
Clinical photopsia features correlated with the causes of photopsias.
Thirty-two photopsia causes were identified. The top 16 included posterior vitreous detachment (PVD) in 39.7% of eyes; retinal tear in 8.9% of eyes; neovascular age-related macular degeneration (AMD) in 7.9% of eyes; rhegmatogenous retinal detachment (RRD) in 7.5% of eyes; classic and ophthalmic migraine in 6.5% of eyes; hypoglycemia in 2.8% of eyes; vertebrobasilar insufficiency in 2.8% of eyes; non-AMD choroidal neovascularization in 2.3% of eyes; retinitis pigmentosa in 1.9% of eyes; severe cough in 1.9% of eyes; central serous chorioretinopathy in 1.4% of eyes; intraocular lens reflections in 0.9% of eyes; blue field entoptic phenomenon in 0.9% of eyes; Charles Bonnet syndrome in 0.9% of eyes; digitalis in 0.9% of eyes; and metastatic adenocarcinoma to the brain in 0.9% of eyes. The photopsias associated with PVD are typically quick (96%), with lightning/flash morphology (96%), white (87%), temporally located (86%), associated with new-onset floaters (85%), preferentially seen in dark (90%) rather than lighted environments (29%), and often initiated by head/eye movements (60%). Retinal detachment had a similar profile, but with more nontemporal photopsias (40%) (P = 0.01). The photopsias from neovascular AMD are more centrally located (83%), quick and repetitive (79%), seen in light (73%) and dark (63%) environments, have no inciting stimuli (84%), and are more likely to be nonwhite (40%).
A pointed history for photopsias can reveal a cause that may not initially seem apparent. Thus, the history can play a key role in management decisions.
评估玻璃体视网膜患者出现光幻视的特征和原因。
横断面研究。
共有 169 例连续玻璃体视网膜疾病患者(217 只眼)出现光幻视病史。
对 169 例 217 只眼的光幻视患者进行评估。光幻视评估包括:(1)偏侧性(单侧、双侧但不同时、双侧且同时);(2)形态(闪光、锯齿状、频闪、闪烁暗点、闪烁、其他);(3)颜色(白色、银色、黄色、组合、其他);(4)位置(颞侧、中央、其他);(5)持续时间(快速、延长、持续、其他);(6)频率;(7)日出现(白天、夜间、两者皆有);(8)刺激(转头或眼、低血糖、高血糖、其他);(9)伴发的全身或眼部体征和症状(头痛、麻木、无力、眩晕、晕厥、复视、低血压、飞蚊症、其他)。
临床光幻视特征与光幻视原因的相关性。
共确定了 32 种光幻视病因。前 16 位病因包括:后玻璃体脱离(PVD)占 39.7%;视网膜裂孔占 8.9%;新生血管性年龄相关性黄斑变性(AMD)占 7.9%;孔源性视网膜脱离(RRD)占 7.5%;经典型和眼科偏头痛占 6.5%;低血糖占 2.8%;椎基底动脉供血不足占 2.8%;非 AMD 脉络膜新生血管化占 2.3%;色素性视网膜炎占 1.9%;剧烈咳嗽占 1.9%;中心性浆液性脉络膜视网膜病变占 1.4%;人工晶状体反射占 0.9%;蓝视野内视现象占 0.9%;Charles Bonnet 综合征占 0.9%;洋地黄中毒占 0.9%;脑转移性腺癌占 0.9%。与 PVD 相关的光幻视通常是快速的(96%),形态为闪电/闪光(96%),颜色为白色(87%),位置在颞侧(86%),伴有新发飞蚊症(85%),在暗处(90%)比在亮处(29%)更常见,常由头/眼运动诱发(60%)。视网膜脱离的光幻视也有类似的特征,但颞侧的光幻视更多(40%)(P=0.01)。新生血管性 AMD 引起的光幻视位置更偏中央(83%),快速且重复(79%),在亮处(73%)和暗处(63%)都能看见,没有诱发刺激(84%),且更可能不是白色(40%)。
对光幻视进行详细的病史询问可以揭示出可能最初不明显的病因。因此,病史在治疗决策中起着关键作用。